Syndexa Pharmaceuticals Corp

Syndexa Pharmaceuticals Corporation develops biopharmaceutical products for cancer treatment. The Company focuses on innovative therapies, commercialization of FDA-approved oncology drugs, and clinical trials for new products. Syndexa Pharmaceuticals Corp serves healthcare providers and oncology specialists in the United States.